Skip to main content
. 2024 Aug 29;11:1421025. doi: 10.3389/fcvm.2024.1421025

Table 2.

Propensity score matching of the impact of imaging modalities .

Variables Angiography alone Intra-vascular imaging P-value
N = 598 N = 598
Characteristics
Male 493 (82.4%) 486 (81.3%) 0.971
Age 62.8 ± 11.4 62.1 ± 9.7 0.579
Hypertension 287 (48.0%) 257 (43.0%) 0.442
Diabetes 102 (17.1%) 116 (19.4%) 0.621
Hyperlipidaemia 245 (40.9%) 180 (30.1%) 0.421
CKD/ESRD 163 (27.3%) 148 (24.7%) 0.784
Smoker 198 (33.1%) 204 (34.1%) 0.836
Clinical presentation
NSTEMI 365 (61.0%) 346 (57.9%) 0.862
STEMI 233 (39.0%) 252 (42.1%) 0.801
Cardiac history
History of MI (>3M) 30 (5.0%) 35 (5.9%) 0.701
History of CHF 42 (7.0%) 37 (6.2%) 0.643
Prior PCI 32 (5.4%) 33 (5.5%) 0.863
LVEF (%) 56.1 ± 9.5 55.6 ± 10.4 0.946
No. vessel disease 0.702
Single 299 (50.0%) 279 (46.7%)
Double 208 (34.8%) 235 (39.2%)
Triple 91 (15.2%) 84 (14.0%)
Target vessel
LM 7 (1.2%) 14 (2.3%) 0.413
LAD 349 (58.4%) 364 (60.9%) 0.697
LCX 135 (22.6%) 103 (17.2%) 0.216
RCA 267 (44.6%) 301 (50.3%) 0.371
No. of stents used 1.6 ± 1.0 2.6 ± 1.1 0.261
Stent length 18.2 ± 6.1 22.1 ± 8.3 <0.001
DES 450 (75.2%) 458 (76.6%) 0.912
BMS 148 (24.7%) 140 (23.4%) 0.892
Laboratory data
T. Cholesterol (mg/dl) 155.1 ± 32.5 158.1 ± 41.2 0.322
LDL-C (mg/dl) 90.1 ± 34.1 93.2 ± 35.2 0.431
eGFR 62.3 ± 24.1 58.1 ± 26.3 0.760
HbA1c 6.70 ± 1.49 6.84 ± 1.22 0.760

BMS, bare metal stent; CHF, congestive heart failure; CKD/ESRD, chronic kidney disease/end stage renal disease; DES, drug eluting stent; eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1C; LAD, left anterior descending coronary artery; LCX, Left circumflex coronary artery; LDL-C, low density lipoprotein cholesterol; LM, left main coronary artery; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NSTEMI, non ST segment elevation myocardial infarction; PCI, percutaneous coronary intervention; RCA, right coronary artery; STEMI, ST segment elevation myocardial infarction.